LungBlog

Researchers have found that 57% of lung cancer patients that undergo thermal ablation survived three years, which is two years longer than the average life expectancy.?

MedPanel announces the launch of Profiles in Non-Small Cell Lung Cancer — United States & Europe, the final release in its 2005-2006 Profiles in Oncology series.

University of York spin out company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.

For years researchers have debated whether smoking affects the lungs of men and women differently. So far, there’s been as much evidence against a sex bias as for one. But that may be starting to change.

Seniors in the early stages of lung cancer who have chemotherapy after surgery live longer and don’t suffer more side-effects than their younger counterparts, according to a Canadian study.

An experimental treatment that uses image-guided radiofrequency waves to kill tumors appears to be highly effective in prolonging the lives of early stage lung?cancer patients who are not candidates for surgery.

McKenna, surgical director of Cedars-Sinai’s Center for Chest Diseases and chief of Thoracic Surgery and Trauma, is a pioneer in video-assisted thoracoscopic surgery (VATS). Since 1989, he has researched and written extensively about the procedures and technologies that make it possible to perform major chest operations through small incisions, reducing hospital stays, pain, recovery times and complication rates.

This clinical trial is studying how well broccoli sprout extract works in preventing lung cancer in smokers.

Women smokers are twice as likely as male smokers to develop lung cancer. Yet, men who fall ill are more likely than women to die from the disease.

According to the results of a small phase II clinical trial conducted in Japan, Iressa? (gefitinib) may have a role in the initial treatment of advanced lung cancer patients who have EGFR gene mutations. These results were published in the Journal of Clinical Oncology.